Binyuan Yan

545 total citations
20 papers, 402 citations indexed

About

Binyuan Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Binyuan Yan has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Biomedical Engineering. Recurrent topics in Binyuan Yan's work include Prostate Cancer Treatment and Research (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Binyuan Yan is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Binyuan Yan collaborates with scholars based in China and United States. Binyuan Yan's co-authors include Jun Pang, Haojie Huang, Hanqi Lei, Yang Kang, Weilu Zhang, Su H, Hui Chen, Yufei Wang, Xiaohui Wen and Kanakaraju Kaliannan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Binyuan Yan

19 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binyuan Yan China 12 215 67 66 56 53 20 402
Shuguang Zhang China 13 265 1.2× 63 0.9× 85 1.3× 76 1.4× 45 0.8× 39 497
Yuwen Xie China 12 268 1.2× 100 1.5× 115 1.7× 32 0.6× 29 0.5× 26 443
Zhenfei Bi China 12 225 1.0× 78 1.2× 50 0.8× 30 0.5× 49 0.9× 20 509
Sung Yong Choi South Korea 13 132 0.6× 56 0.8× 38 0.6× 24 0.4× 46 0.9× 29 485
Minyue Zhang China 10 190 0.9× 34 0.5× 33 0.5× 53 0.9× 29 0.5× 25 526
Qiuyi Choo Singapore 9 221 1.0× 56 0.8× 56 0.8× 30 0.5× 35 0.7× 10 442
Miaojuan Qiu China 13 202 0.9× 49 0.7× 27 0.4× 23 0.4× 73 1.4× 21 425
Xinyi Luo China 12 262 1.2× 31 0.5× 78 1.2× 13 0.2× 94 1.8× 30 507

Countries citing papers authored by Binyuan Yan

Since Specialization
Citations

This map shows the geographic impact of Binyuan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binyuan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binyuan Yan more than expected).

Fields of papers citing papers by Binyuan Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binyuan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binyuan Yan. The network helps show where Binyuan Yan may publish in the future.

Co-authorship network of co-authors of Binyuan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Binyuan Yan. A scholar is included among the top collaborators of Binyuan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binyuan Yan. Binyuan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Rui, Jiang Peng, Binyuan Yan, et al.. (2025). DNA2 protein destruction dictates DNA hyperexcision, cGAS–STING activation, and innate immune response in CDK12-deregulated cancers. Proceedings of the National Academy of Sciences. 122(28). e2413732122–e2413732122.
2.
Zhang, Hao, Chengyuan Xing, Binyuan Yan, et al.. (2024). Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy. Biomacromolecules. 25(6). 3685–3702. 4 indexed citations
3.
Yan, Binyuan, et al.. (2024). An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. British Journal of Cancer. 131(5). 870–882. 1 indexed citations
4.
Xing, Chengyuan, Hanqi Lei, Binyuan Yan, et al.. (2024). ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment. Journal of Controlled Release. 368. 637–649. 16 indexed citations
5.
Xing, Chengyuan, et al.. (2024). Carrier-Free Small Molecule-Assembled Nanoparticles for Treatment of Sepsis. ACS Applied Nano Materials. 7(20). 24049–24060. 3 indexed citations
6.
Sun, Rui, Binyuan Yan, Hao Li, et al.. (2023). Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis. Cancer Research. 83(19). 3192–3204. 25 indexed citations
7.
Li, Xiang, Bo Tang, Hao Li, et al.. (2023). SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer Research. 83(6). 875–889. 23 indexed citations
8.
Yang, Chunguang, Yingqiu Song, Jianxi Wang, et al.. (2023). Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer. Advanced Science. 10(36). e2302368–e2302368. 12 indexed citations
9.
Wang, Yiyao, Hanqi Lei, Binyuan Yan, et al.. (2023). Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer. Acta Biomaterialia. 168. 593–605. 27 indexed citations
10.
Guan, Yupeng, Hanqi Lei, Chengyuan Xing, et al.. (2023). Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P‐Glycoprotein and Ferroptosis. Advanced Healthcare Materials. 13(3). e2301345–e2301345. 14 indexed citations
11.
Xia, Heng, Shiqiang Zhang, Hanqi Lei, et al.. (2023). Delivery of mRNA Vaccine with 1, 2‐Diesters‐Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy. Advanced Healthcare Materials. 13(5). e2302691–e2302691. 11 indexed citations
12.
Tang, Bo, Yinhui Yang, Zhaogang Yang, et al.. (2021). MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression. Cancer Research. 81(17). 4471–4484. 11 indexed citations
13.
Shi, Lei, Yuqian Yan, Yundong He, et al.. (2021). Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression. Cancer Research. 81(13). 3593–3606. 25 indexed citations
14.
Zhang, Xinyu, Dandan Li, Jun Huang, et al.. (2018). Screening of pH-responsive long-circulating polysaccharide–drug conjugate nanocarriers for antitumor applications. Journal of Materials Chemistry B. 7(2). 251–264. 47 indexed citations
15.
Hao, Junsheng, et al.. (2018). Stimulation of KLF14/PLK1 pathway by thrombin signaling potentiates endothelial dysfunction in Type 2 diabetes mellitus. Biomedicine & Pharmacotherapy. 99. 859–866. 21 indexed citations
16.
Yan, Binyuan, et al.. (2018). Consumption of processed and pickled food and esophageal cancer risk: A systematic review and meta-analysis. Bulletin du Cancer. 105(11). 992–1002. 9 indexed citations
17.
Zhang, Lili, Jing Ma, Bo Yang, et al.. (2018). Interference with lactate metabolism by mmu-miR-320-3p via negatively regulating GLUT3 signaling in mouse Sertoli cells. Cell Death and Disease. 9(10). 964–964. 28 indexed citations
18.
Yuan, Xiaojie, Zhaohua Ji, Jie Gao, et al.. (2018). Green Tea Liquid Consumption Alters the Human Intestinal and Oral Microbiome. Molecular Nutrition & Food Research. 62(12). e1800178–e1800178. 103 indexed citations
19.
Zhao, Yong, et al.. (2017). Regulation of testicular steroidogenesis by Foxa3 via transcriptional modulation of ERα signaling in type 2 diabetes mellitus (T2DM). Biochemical and Biophysical Research Communications. 490(3). 786–793. 17 indexed citations
20.
Song, Chaojun, Binyuan Yan, Lihua Chen, et al.. (2009). Novel Immunohistochemical Monoclonal Antibody Against Rat B Cell Receptor Associated Protein 31 (BAP31). Hybridoma. 28(5). 363–367. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuguang Zhang Breakdown of academic impact, for papers by Yuwen Xie Breakdown of academic impact, for papers by Zhenfei Bi Breakdown of academic impact, for papers by Sung Yong Choi Breakdown of academic impact, for papers by Minyue Zhang Breakdown of academic impact, for papers by Qiuyi Choo Breakdown of academic impact, for papers by Miaojuan Qiu Breakdown of academic impact, for papers by Xinyi Luo
Rankless by CCL
2026